Supernus Pharmaceuticals, Inc.

Senior Medical Science Liaison - ADHD

Supernus Pharmaceuticals, Inc.  •  $170k - $194k/yr  •  United States (Remote)  •  3 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.
53
AI Success™

Job Description

Supernus Pharmaceuticals is an award-winning biopharmaceutical company with more than 30 years of experience in developing and commercializing products that treat central nervous system (CNS) diseases. At Supernus, we develop innovative products that help treat neurological and psychiatric conditions. At Supernus, we develop innovative products that help treat neurological and psychiatric conditions. We currently have 8 products in the market that are making a real impact on patient outcomes.

The Senior Medical Science Liaison is a Medical Affairs professional that is dedicated to bridging the gap between Supernus and the medical community. This role functions as a scientific expert, educating healthcare professionals (HCPs), building relationships with Key Opinion Leaders (KOLs), and collecting real-world insights on Attention-Deficit/Hyperactivity Disorder, Depressive Disorders, other neuropsychiatric conditions, and treatment.

Essential Duties & Responsibilities:

  • Establish and maintain peer-to-peer relationships with regional/national KOLs, HCPs, academic centers, and health care systems.
  • Function as the subject matter expert on clinical and medical information for relevant neuroscience specialty areas.
  • Provides scientifically accurate, compliant responses to unsolicited requests for medical information.
  • Provide compliant educational programs and presentations to HCPs and healthcare systems.
  • Identify, develop, and execute regional territory plans for compliant medical personnel engagement aligned with Medical Affairs (MA) strategies.
  • Assist the Medical Affairs Department and the Medical Team in field-based medical operations.
  • Collaborate with cross-functional partners, including Commercial Sales and Marketing, Corporate Accounts, Medical Affairs, R & D, Regulatory, and Legal.
  • Contribute to the Medical Affairs strategic and tactical development plans.
  • Liaise with business partners as needed.
  • Participates in strategic initiatives and leads Medical Affairs projects.
  • Other responsibilities and projects assigned.

Supervisory Responsibilities:

  • N/A.

Knowledge & Other Qualifications:

  • MD, PharmD, PhD or Doctor of Nursing, or other neuroscience degree with a minimum of three years of experience in Medical Affairs required.
  • Five years of pharmaceutical industry experience preferred.
  • Previous clinical or research experience in psychiatry, neurology, or neuroscience is preferred.
  • Previous experience with product launches, clinical development, or Pharmacoeconomics is a plus.

Other Characteristics:

  • Ability to work independently and as part of a team and maintain high ethical standards of integrity and quality.
  • Ability to have an innovative and dynamic approach to work.
  • A self-starter able to work independently but comfortable working in a team environment.
  • Ability to consistently exhibit Supernus Values in interactions with employees at all levels of the organization, vendors, customers, and others.
  • Capable of performing other duties as assigned by Management.
  • Authorized to legally work in the United States without visa sponsorship.

Physical Requirements/Work Environment/Travel Requirements:

  • Travel Required: up to 50-75% Travel.
  • This remote position requires routine access to an adequately private work location to allow for compliant discussion of confidential information.
  • This role primarily involves sedentary work and may require exertion of up to 20 pounds of force occasionally and/or carrying objects.
  • This role requires adequate close visual acuity to perform activities such as extensive reading; preparing and analyzing data and figures; transcribing; viewing a computer screen, iPad, or other electronic device for extended periods of time; and adequate distance visual acuity to view presentations in large conference rooms.
  • This role is not expected to involve substantial exposure to adverse environmental conditions.

Compensation:

At Supernus, we offer a competitive compensation package that reflects your experiences and contributions. The expected salary range for fully qualified candidates applying for this role is $170,000 to $194,000. This range is what the Company reasonably expects to offer for the position and is not reflective of the full compensation scale of the role. This range may be modified in the future. An individual’s salary within the range is based on multiple factors, which may include and are not limited to education, relevant experience, knowledge, length of industry experience and organizational needs.

You also will be able to participate in a competitive benefits package, including but not limited to: health, dental, vision, paid time off, 401k company match, company paid life insurance and health and wellness benefits. The total compensation package for this position also includes other compensation elements such as stock equity awards, employee stock purchase programs and participation in our Company’s discretionary annual bonus program.

Supernus Pharmaceuticals is an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, national origin, disability, protected veteran status, age or any other characteristic protected by law.

Supernus Pharmaceuticals, Inc.

About Supernus Pharmaceuticals, Inc.

We are a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Our extensive expertise in product development has been built over the past 30 years: initially as a standalone development organization, then as a U.S. subsidiary of Shire plc and, in late 2005, as Supernus Pharmaceuticals Inc. We market our products in the United States through our own specialty sales force and seek strategic collaborations with other pharmaceutical companies to license our products outside the United States.

We market Qelbree® (viloxazine extended-release) for the treatment of attention deficit/hyperactivity disorder (ADHD) in children ages 6 to 17. Trokendi XR® (extended-release topiramate) for the prophylaxis of migraine and the treatment of epilepsy, Oxtellar XR® (extended-release oxcarbazepine) for the treatment of epilepsy, Apokyn® (apomorphine hydrochloride injection) for the acute treatment of hypomobility in advanced Parkinson’s disease (PD), Myobloc® (rimabotulinumtoxinB) for the treatment of cervical dystonia and treatment of chronic sialorrhea in adults, and Xadago® (safinamide) as an adjunctive treatment to levodopa/carbidopa in PD patients with hypomobility.

We are also developing several product candidates to address large market opportunities in the CNS market, including SPN-812 for the treatment of ADHD in adults, apomorphine infusion pump for hypomobility in PD, SPN-820 (NV-5138) for treatment-resistant depression, and SPN-817 for the treatment of epilepsy.

Industry
Chemicals & Materials
Company Size
501-1,000 employees
Headquarters
Rockville, Maryland
Year Founded
2005
Social Media